Impact of CD40 gene polymorphisms on the risk of immune thrombocytopenic purpura-Reference-Cited by-同舟云学术

Impact of CD40 gene polymorphisms on the risk of immune thrombocytopenic purpura

Published:2020-04 Issue: Volume:736 Page:144419
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

AbdelGhafar Muhammad Tarek,El-Kholy Rasha A.,Elbedewy Tamer A.,Allam Alzahraa A.,Eissa Radwa Abd Elmotaleb,Samy Sara Mina,El-Khalik Sara Ragab Abd,Rabah Hanem

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference46 articles.

1. The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance;Akiyama;Immunity,2008

2. Cellular expression of CD markers in immune thrombocytopenic purpura: implications for prognosis;Behzad;APMIS,2018

3. TRAF proteins in CD40 signaling;Bishop;Adv. Exp. Med. Biol.,2007

4. CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility;Blanco-Kelly;PLoS One,2010

5. CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis;Buchner;J. Pathol.,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FOXO1 Single-Nucleotide Polymorphisms Are Associated with Bleeding Severity and Sensitivity of Glucocorticoid Treatment of Pediatric Immune Thrombocytopenia;DNA and Cell Biology;2024-06-01

2. Impact of CD40 gene variants [(rs1883832) and (rs4810485)] on the risk of immune thrombocytopenic purpura in Egyptian paediatric patients: a case-control study;The Egyptian Journal of Haematology;2024-01

3. Multi-omics Insights Into Autoimmune Thrombocytopenic Purpura;Comprehensive Hematology and Stem Cell Research;2024

4. Impact of CD40 gene polymorphisms on the risk of cervical squamous cell carcinoma: a case-control study;BMC Cancer;2023-09-11

5. Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP;Blood Advances;2023-07-18